205.5365 Prohibition on expenditure of Medicaid funds for cross-sex hormones for
98 words·~1 min read·
/ky/205-5365A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
treatment of gender dysphoria or gender reassignment surgery. Notwithstanding any provision of law to the contrary and unless required under federal law, the Department for Medicaid Services and any managed care organization with whom the department contracts for the delivery of Medicaid services are hereby prohibited from expending any Medicaid funds on any of the following:
(1)Cross-sex hormones when prescribed or administered primarily or solely for the
treatment of gender dysphoria; and
(2)Gender reassignment surgery to alter or remove physical or anatomical
characteristics or features that are typical for and characteristic of a person's
biological sex.